CME/CE
Popular
Prof. Dr. Johann Bauersachs
Carolyn S. P. Lam, MBBS, PhD, MRCP, MS, FACC, FAMS, FESC
Richard E. Pratley, MD
David Cherney, MD, PhD
prof. Hiddo Heerspink
Carolyn S. P. Lam, MBBS, PhD, MRCP, MS, FACC, FAMS, FESC
Javed Butler, MD
Stephen J. Greene, MD, FACC, FHFSA
- CME/CE Broadcast Replay
Optimizing Outcomes in Patients With oHCM: The Emerging Role of Cardiac Myosin Inhibitors
0.50 creditsIacopo Olivotto, MD
Ahmad Masri, MD, MS
Pablo Garcia-Pavia, MD, PhD
Fabian Knebel, MD, PhD
Caroline Coats, MD
- CME/CE Broadcast Replay
Crossing Boundaries: CETP Inhibitors and the Next Frontier in Lipid Control
0.50 credits
Prof. Ulrich Laufs
Pam R. Taub, MD, FACC, FASPC
Prof. John Kastelein, Chief Scientific Officer, NewAmsterdam Pharma
Christie Ballantyne, MD
- Cardiology
Latest Data Publication on Quantifying the Link Between TTR Response and Mortality Reduction
Daniel Judge, MD
- Cardiology
Breaking New Ground: Acoramidis Reduces AF Events in ATTR CM Patients from ESC Heart Failure 2025
Kevin Alexander, MD
Rajiv Agarwal, MBBS, MD, FASN, BRCU
Amy Mottl, MD, MPH
Muthiah Vaduganathan, MD, MPH
Ahmad Masri, MD, MS
Amy Mottl, MD, MPH
Prof. Christoph Wanner
Riccardo Maria Inciardi, MD, PhD
Ty J. Gluckman, MD, MHA, FACC, FAHA, FASPC
Rishi Wadhera, MD, MPP, Mphil
- MinuteCE®
Expanding Access: Alternative Models for Delivering Lipid-Lowering Therapy
1.00 program creditRishi Wadhera, MD, MPP, Mphil
Ty J. Gluckman, MD, MHA, FACC, FAHA, FASPC
- MinuteCE®
Personalizing LDL-C Treatment—Novel Options That Align With Patient Preferences
1.00 program creditTy J. Gluckman, MD, MHA, FACC, FAHA, FASPC
Rishi Wadhera, MD, MPP, Mphil
Ty J. Gluckman, MD, MHA, FACC, FAHA, FASPC
Rishi Wadhera, MD, MPP, Mphil
